« back to directory

Company Profile

QUE Oncology

  •  
  •  

About QUE Oncology

QUE Oncology is a privately held Melbourne-based clinical stage biotech company focused on innovative medicines to improve the tolerability of current anti-cancer treatments. QUE’s lead program Q-122 is a novel first-in-class drug for the treatment of severe hot flushes and night sweats in breast cancer patients who are undergoing anti-hormonal therapy. Currently in a global multi-centre phase 2 trial, the aim is to bring to market drugs that substanially improve the quality of life of cancer patients worldwide.